We are live on ! Find out more
COCP icon

Cocrystal Pharma
COCP

27 hedge funds and large institutions have $3.95M invested in Cocrystal Pharma in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.06% less ownership

Funds ownership: 1.22% → 1.16% (-0.06%)

18% less funds holding

Funds holding: 33 → 27 (-6)

32% less capital invested

Capital invested by funds: $5.83M → $3.95M (-$1.88M)

50% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 6

67% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 9

Holders
27
Holders Change
-6
Holders Change %
-18.18%
% of All Funds
0.47%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
3
Reduced
6
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$31.2K
2
VF
Virtu Financial
New York
+$18.7K
3
Millennium Management
Millennium Management
New York
+$4.12K
4
TSS
Two Sigma Securities
New York
+$2.83K
5
TRCT
Tower Research Capital (TRC)
New York
+$2.7K

Top Sellers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
-$236K
2
Renaissance Technologies
Renaissance Technologies
New York
-$38.2K
3
BJL
Brighton Jones LLC
Washington
-$11K
4
WWM
Western Wealth Management
Colorado
-$10K
5
Jane Street
Jane Street
New York
-$6K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$1.54M -$236K -50,389 -10%
Vanguard Group
2
Vanguard Group
Pennsylvania
$948K – – –
Renaissance Technologies
3
Renaissance Technologies
New York
$467K -$38.2K -8,151 -6%
BlackRock
4
BlackRock
New York
$259K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$235K – – –
Morgan Stanley
6
Morgan Stanley
New York
$156K – – –
State Street
7
State Street
Massachusetts
$85K – – –
PA
8
Parallel Advisors
California
$53K – – –
Verition Fund Management
9
Verition Fund Management
Connecticut
$47K – – –
Northern Trust
10
Northern Trust
Illinois
$42K – – –
Bank of America
11
Bank of America
North Carolina
$31K – – –
Citadel Advisors
12
Citadel Advisors
Florida
$23K +$31.2K +6,660 New
VF
13
Virtu Financial
New York
$14K +$18.7K +4,001 New
Bank of New York Mellon
14
Bank of New York Mellon
New York
$13K – – –
TRCT
15
Tower Research Capital (TRC)
New York
$10K +$2.7K +577 +27%
Commonwealth Equity Services
16
Commonwealth Equity Services
Massachusetts
$7K -$604 -129 -6%
TSS
17
Two Sigma Securities
New York
$6K +$2.83K +604 +57%
BRWA
18
B. Riley Wealth Advisors
Florida
$4K – – –
Millennium Management
19
Millennium Management
New York
$3K +$4.12K +880 New
UBS Group
20
UBS Group
Switzerland
$2K +$1.63K +348 +297%
JP Morgan Chase
21
JP Morgan Chase
New York
$1K -$1.67K -356 -52%
CYG
22
Clean Yield Group
Vermont
$1K – – –
AIC
23
Archer Investment Corporation
Indiana
$291 – – –
BJL
24
Brighton Jones LLC
Washington
– -$11K -2,333 Closed
WWM
25
Western Wealth Management
Colorado
– -$10K -1,901 Closed
1
2

COCP Hedge Fund Activity: Q3 2022 in Review

27 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Cocrystal Pharma (COCP) for Q3 2022, worth a combined $3.95M — down 32% from $5.83M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of COCP and 3 opened new positions — a net loss of 6 holders — while 6 trimmed existing stakes and 3 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $31.2K. The largest seller was Sabby Management, cutting an estimated $236K.

  • 27 institutional investors held Cocrystal Pharma (COCP) as of Q3 2022, down from 33 in Q2 2022.
  • Funds reported $3.95M of Cocrystal Pharma stock for Q3 2022, down 32% quarter-over-quarter.
  • 3 funds opened new Cocrystal Pharma positions in Q3 2022 and 9 closed out, a net change of -6 holders.
  • The largest Cocrystal Pharma buyer in Q3 2022 was Citadel Advisors, an estimated $31.2K added.
  • The largest Cocrystal Pharma seller in Q3 2022 was Sabby Management, an estimated $236K sold.

Based on aggregated 13F filings for Q3 2022.